NewslettersHuman Immunology News Polymer-Based Antibody Mimetics (iBodies) Target Human PD-L1 and Function as a Potent Immune Checkpoint Blocker By Jamie Kang - April 30, 2024 0 Scientists reported the development of polymer-based anti-human PD-L1 antibody mimetics by attaching the macrocyclic peptide WL12 to a N-(2-hydroxypropyl)methacrylamide copolymer. [Journal Of Biological Chemistry] Full Article